作为治疗黑色素瘤的Talimogene laherparepvec (T-VEC):系统性审查
Sai Santhosha Mrudula Alla1, Yogesh Tekuru2, Moraboina Sai Lokesh3
1Andhra Medical College, Visakhapatnam, Andhra Pradesh, India.
概括
在黑色素瘤患者中,Talimogene laherparepvec (T-VEC) 改善了客观反应率 (ORR) 和持久反应率 (DRR). 需要进一步的研究来探索组合疗法和管理T-VEC.
科学领域:
- 在瘤学瘤学.
- 病毒学 病毒学
- 免疫治疗是一种免疫疗法.
背景情况:
- 黑色素瘤的发病率正在上升,这对公众健康构成了重大挑战.
- 塔利莫基因拉赫帕雷普韦克 (T-VEC),一种瘤病毒,在黑色素瘤治疗中显示出有效性,但具有相关的副作用.
- 与T-VEC和免疫检查点抑制剂的联合治疗正在研究以提高治疗结果.
研究的目的:
- 系统地审查Talimogene laherparepvec (T-VEC) 在黑色素瘤治疗中的疗效和安全性.
- 分析与T-VEC治疗相关的治疗结果,包括客观反应率 (ORR) 和持久反应率 (DRR).
- 确定和总结T-VEC治疗在黑色素瘤患者的不良影响.
主要方法:
- 按照PRISMA的指导方针,对主要数据库 (PubMed,Scopus,Web of Science,Google Scholar,ProMED) 进行了系统的文献搜索.
- 分析了15项研究的数据,包括队列,病例报告,病例系列和随机对照试验.
- 患者的人口统计,治疗细节 (持续时间,剂量),反应率 (DRR,ORR) 和不良事件被提取和表格化.
主要成果:
- 该审查包括779名患有IIIB至IV阶段黑色素瘤的患者,平均年龄为65岁.
- 治疗T-VEC的结果是平均持久反应率 (DRR) 为41.87%和客观反应率 (ORR) 为62.2%.
- 最常见的不良反应是寒 (21.69%),发烧 (20.41%),和类似流感的疾病 (14.89%).
结论:
- 在改善黑色素瘤患者的客观反应率 (ORR) 和持久反应率 (DRR) 方面,塔利摩根拉赫帕雷普韦克 (T-VEC) 显示出显著的有效性.
- 通常观察到的副作用包括寒,发烧和类似流感的症状.
- 需要进一步研究涉及T-VEC的组合疗法及其安全性,以优化黑色素瘤治疗策略.
相关概念视频
01:27Tumor Immunotherapy
468
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
468
01:30Cancer Vaccines
333
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
333
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K